Not applicableNot Yet RecruitingNCT05271110What this trial is testingSurgery for Liver Metastases From PDACWho this might be right forDisseminated Pancreatic Cancer Linkoeping University 64
Not applicableLooking for participantsNCT05526443What this trial is testingAustrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Who this might be right forPancreatic CancerAdvanced Pancreatic Carcinoma Medical University of Graz 1,500
Early research (Phase 1)Active Not RecruitingNCT04117087What this trial is testingPooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic CancerWho this might be right forColorectal CancerPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678593What this trial is testingGFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS MutationWho this might be right forAdvanced Solid Tumors CancerPancreatic Ductal AdenocarcinomaRAS Mutation Genfleet Therapeutics (Shanghai) Inc. 222
Not applicableStudy completedNCT06461598What this trial is testingSignature for Precise Chemosensitivity Prediction in PDACWho this might be right forPancreatic Cancer Ruijin Hospital 365
Not applicableNot Yet RecruitingNCT06616688What this trial is testingInnovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC) IRCCS San Raffaele 50
Testing effectiveness (Phase 2)Looking for participantsNCT07114861What this trial is testingThe KN510713 Study in Combination With mFOLFIRINOXWho this might be right forLocally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) New Cancer Cure-Bio Co.,Ltd. 30
Early research (Phase 1)Study completedNCT04672434What this trial is testingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 48
Not applicableEnrolling By InvitationNCT06157671What this trial is testingThe LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaPancreatic Intraepithelial Neoplasia Adenocyte, LLC 1,000
Not applicableStudy completedNCT06947395What this trial is testingClinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)Who this might be right forCancer of the PancreasPancreatic CancerPancreas Neoplasms+2 more Immunovia, Inc. 386
Not applicableNot Yet RecruitingNCT07605702What this trial is testingThe Canopy Cancer Collective Clinical Registry ProtocolWho this might be right forGastrointestinal NeoplasmsPancreatic CancerColorectal Cancer+4 more Canopy Cancer Collective, LLC 100,000
Early research (Phase 1)Study completedNCT04943900What this trial is testingBMS-986416 With and Without Nivolumab in Select Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 67
Testing effectiveness (Phase 2)Ended earlyNCT05716295What this trial is testingA Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Medikine, Inc. 26
Not applicableNot Yet RecruitingNCT05895214What this trial is testingMesopancreas Study in Pancreatic CancerWho this might be right forPDACPancreatoduodenectomyMargin, Resection+2 more Heinrich-Heine University, Duesseldorf 500
Not applicableStudy completedNCT02150746What this trial is testingCirculating Tumor Cells in Operative BloodWho this might be right forCarcinoma, Pancreatic Ductal University of Florida 3
Testing effectiveness (Phase 2)Looking for participantsNCT07483983What this trial is testingStudy Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/ResistanceWho this might be right forMetastatic/Locally Advanced Non-Small-Cell Lung CancerMetastatic/Locally Pancreatic Ductal Adenocarcinoma Gustave Roussy, Cancer Campus, Grand Paris 60
Not applicableLooking for participantsNCT07587866What this trial is testingPanuri Performance StudyWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC) Urteste S.A 1,100
Not applicableEnded earlyNCT05515705What this trial is testingFirst-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical StudyWho this might be right forPancreatic Disease IHU Strasbourg 21
Testing effectiveness (Phase 2)Looking for participantsNCT07303465What this trial is testingTo Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.Who this might be right forKRAS G12D MutationsPancreatic Ductal Adenocarcinoma (PDAC) Ranok Therapeutics (Hangzhou) Co., Ltd. 60
Not applicableTemporarily pausedNCT04700488What this trial is testingMagnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)Who this might be right forPDAC - Pancreatic Ductal Adenocarcinoma Cedars-Sinai Medical Center 36